BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29031088)

  • 21. Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer's disease.
    Rasmussen J; Mahler J; Beschorner N; Kaeser SA; Häsler LM; Baumann F; Nyström S; Portelius E; Blennow K; Lashley T; Fox NC; Sepulveda-Falla D; Glatzel M; Oblak AL; Ghetti B; Nilsson KPR; Hammarström P; Staufenbiel M; Walker LC; Jucker M
    Proc Natl Acad Sci U S A; 2017 Dec; 114(49):13018-13023. PubMed ID: 29158413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer's disease.
    Du F; Yu Q; Yan S; Hu G; Lue LF; Walker DG; Wu L; Yan SF; Tieu K; Yan SS
    Brain; 2017 Dec; 140(12):3233-3251. PubMed ID: 29077793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration.
    Weston PSJ; Poole T; Ryan NS; Nair A; Liang Y; Macpherson K; Druyeh R; Malone IB; Ahsan RL; Pemberton H; Klimova J; Mead S; Blennow K; Rossor MN; Schott JM; Zetterberg H; Fox NC
    Neurology; 2017 Nov; 89(21):2167-2175. PubMed ID: 29070659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tau hyperphosphorylation induces oligomeric insulin accumulation and insulin resistance in neurons.
    Rodriguez-Rodriguez P; Sandebring-Matton A; Merino-Serrais P; Parrado-Fernandez C; Rabano A; Winblad B; Ávila J; Ferrer I; Cedazo-Minguez A
    Brain; 2017 Dec; 140(12):3269-3285. PubMed ID: 29053786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) Project.
    van Maurik IS; Zwan MD; Tijms BM; Bouwman FH; Teunissen CE; Scheltens P; Wattjes MP; Barkhof F; Berkhof J; van der Flier WM;
    JAMA Neurol; 2017 Dec; 74(12):1481-1491. PubMed ID: 29049480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo staging of regional amyloid deposition.
    Grothe MJ; Barthel H; Sepulcre J; Dyrba M; Sabri O; Teipel SJ;
    Neurology; 2017 Nov; 89(20):2031-2038. PubMed ID: 29046362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disease and Region Specificity of Granulin Immunopositivities in Alzheimer Disease and Frontotemporal Lobar Degeneration.
    Mao Q; Wang D; Li Y; Kohler M; Wilson J; Parton Z; Shmaltsuyeva B; Gursel D; Rademakers R; Weintraub S; Mesulam MM; Xia H; Bigio EH
    J Neuropathol Exp Neurol; 2017 Nov; 76(11):957-968. PubMed ID: 29044416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer's disease.
    Branca C; Ferreira E; Nguyen TV; Doyle K; Caccamo A; Oddo S
    Hum Mol Genet; 2017 Dec; 26(24):4823-4835. PubMed ID: 29036636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropathologic Correlates of Psychiatric Symptoms in Alzheimer's Disease.
    Ehrenberg AJ; Suemoto CK; França Resende EP; Petersen C; Leite REP; Rodriguez RD; Ferretti-Rebustini REL; You M; Oh J; Nitrini R; Pasqualucci CA; Jacob-Filho W; Kramer JH; Gatchel JR; Grinberg LT
    J Alzheimers Dis; 2018; 66(1):115-126. PubMed ID: 30223398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. USP7 small-molecule inhibitors interfere with ubiquitin binding.
    Kategaya L; Di Lello P; Rougé L; Pastor R; Clark KR; Drummond J; Kleinheinz T; Lin E; Upton JP; Prakash S; Heideker J; McCleland M; Ritorto MS; Alessi DR; Trost M; Bainbridge TW; Kwok MCM; Ma TP; Stiffler Z; Brasher B; Tang Y; Jaishankar P; Hearn BR; Renslo AR; Arkin MR; Cohen F; Yu K; Peale F; Gnad F; Chang MT; Klijn C; Blackwood E; Martin SE; Forrest WF; Ernst JA; Ndubaku C; Wang X; Beresini MH; Tsui V; Schwerdtfeger C; Blake RA; Murray J; Maurer T; Wertz IE
    Nature; 2017 Oct; 550(7677):534-538. PubMed ID: 29045385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caspase-6 Knockout in the 5xFAD Model of Alzheimer's Disease Reveals Favorable Outcome on Memory and Neurological Hallmarks.
    Angel A; Volkman R; Royal TG; Offen D
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32050445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specificity for latent C termini links the E3 ubiquitin ligase CHIP to caspases.
    Ravalin M; Theofilas P; Basu K; Opoku-Nsiah KA; Assimon VA; Medina-Cleghorn D; Chen YF; Bohn MF; Arkin M; Grinberg LT; Craik CS; Gestwicki JE
    Nat Chem Biol; 2019 Aug; 15(8):786-794. PubMed ID: 31320752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in Alzheimer's disease.
    Matchett BJ; Grinberg LT; Theofilas P; Murray ME
    Acta Neuropathol; 2021 May; 141(5):631-650. PubMed ID: 33427939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterization of selectively vulnerable neurons in Alzheimer's disease.
    Leng K; Li E; Eser R; Piergies A; Sit R; Tan M; Neff N; Li SH; Rodriguez RD; Suemoto CK; Leite REP; Ehrenberg AJ; Pasqualucci CA; Seeley WW; Spina S; Heinsen H; Grinberg LT; Kampmann M
    Nat Neurosci; 2021 Feb; 24(2):276-287. PubMed ID: 33432193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonergic dysfunction may mediate the relationship between alcohol consumption and Alzheimer's disease.
    Pierson SR; Kolling LJ; James TD; Pushpavathi SG; Marcinkiewcz CA
    Pharmacol Res; 2024 May; 203():107171. PubMed ID: 38599469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical Cellular/Tissue and Molecular Aspects Regarding Nonpharmacological Interventions in Alzheimer's Disease-A Systematic Review.
    Aurelian S; Ciobanu A; Cărare R; Stoica SI; Anghelescu A; Ciobanu V; Onose G; Munteanu C; Popescu C; Andone I; Spînu A; Firan C; Cazacu IS; Trandafir AI; Băilă M; Postoiu RL; Zamfirescu A
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reevaluating tau reduction as a therapeutic approach for tauopathies: Insights and perspectives.
    Sun X; Ogbolu VC; Baas PW; Qiang L
    Cytoskeleton (Hoboken); 2024 Jan; 81(1):57-62. PubMed ID: 37819557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective Noradrenaline Depletion in the Neocortex and Hippocampus Induces Working Memory Deficits and Regional Occurrence of Pathological Proteins.
    Prinzi C; Kostenko A; de Leo G; Gulino R; Leanza G; Caccamo A
    Biology (Basel); 2023 Sep; 12(9):. PubMed ID: 37759663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cogs in the autophagic machine-equipped to combat dementia-prone neurodegenerative diseases.
    de Wet S; Theart R; Loos B
    Front Mol Neurosci; 2023; 16():1225227. PubMed ID: 37720551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Molecular Mechanisms of Neuroinflammation in Alzheimer's Disease, the Consequence of Neural Cell Death.
    Choi SB; Kwon S; Kim JH; Ahn NH; Lee JH; Yang SH
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.